LPS (lipopolysaccharide) is an endotoxin found in the outer membrane of Gram-negative bacteria.
Structural difference:
- Penta-acylated LPS (5 fatty acid chains): Less inflammatory, sometimes even immunomodulatory
- Hexa-acylated LPS (6 fatty acid chains): More pro-inflammatory, strongly activates TLR4 receptors
Why it matters: Not all LPS is equally inflammatory. Hexa-LPS is specifically associated with:
- Increased intestinal permeability ("leaky gut")
- Metabolic endotoxemia
- Systemic inflammation
- Insulin resistance and metabolic syndrome
Clinical interpretation:
- High hexa-LPS capacity suggests greater inflammatory potential
- Correlates with the abundance of organisms like E. coli, Klebsiella, Desulfovibrio
- May warrant interventions to reduce Gram-negative overgrowth or strengthen barrier function
Important: This measures genetic capacity to produce hexa-LPS, not actual circulating endotoxin levels (which would require serum LPS testing).
Comments
0 comments
Article is closed for comments.